Y, L., P, C., M, S., W, Z., J, H., B, W., . . . H, H. (2026). Thrombosis-related gene signature predicts prostate cancer recurrence and immune therapy: Insights from retrospective cohorts, bioinformatics, and experimental validation. Inflammation research : official journal of the European Histamine Research Society ... [et al.], 75(1), 41. https://doi.org/10.1007/s00011-025-02138-w
Chicago Style (17th ed.) CitationY, Luo, Chen P, Situ M, Zhuang W, Huang J, Wang B, Wang Q, Peng S, and Huang H. "Thrombosis-related Gene Signature Predicts Prostate Cancer Recurrence and Immune Therapy: Insights from Retrospective Cohorts, Bioinformatics, and Experimental Validation." Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.] 75, no. 1 (2026): 41. https://doi.org/10.1007/s00011-025-02138-w.
MLA (9th ed.) CitationY, Luo, et al. "Thrombosis-related Gene Signature Predicts Prostate Cancer Recurrence and Immune Therapy: Insights from Retrospective Cohorts, Bioinformatics, and Experimental Validation." Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.], vol. 75, no. 1, 2026, p. 41, https://doi.org/10.1007/s00011-025-02138-w.